Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Convertible Debt (2017 - 2022)

CV Sciences (CVSI) has disclosed Convertible Debt for 4 consecutive years, with $2.1 million as the latest value for Q4 2022.

  • Quarterly Convertible Debt rose 100.0% to $2.1 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2022, up 100.0% year-over-year, with the annual reading at $2.1 million for FY2022, 100.0% up from the prior year.
  • Convertible Debt hit $2.1 million in Q4 2022 for CV Sciences, roughly flat from $2.1 million in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $2.1 million in Q1 2022 to a low of $1.1 million in Q4 2021.